US Patent 7514422 5HT
Patent 7514422 was granted and assigned to Arena Pharmaceuticals on April, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+79 characters)
Article
Patent abstract
The present invention relates to novel compounds of Formula (I):
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07514422 5HT US Patent 7514422 5HT
Infobox
Patent Number
0751442200
Patent Number
751442200
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075144220
Date of Patent
April 7, 2009
0Patent Application Number
109179790
Date Filed
August 13, 2004
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075144220
Date of Patent
April 7, 2009
0Patent Application Number
109179790
Date Filed
August 13, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07514422 5HT
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07514422
Date of patent
April 7, 2009
Patent application number
10917979
Date Filed
August 13, 2004
Patent primary examiner
Find more entities like US Patent 7514422 5HT
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
